Affiliation:
1. Department of Pharmacy People's Hospital of Peking University Beijing China
2. Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science Peking University Beijing China
Abstract
AbstractIndividual differences in drug response have always existed in clinical treatment. Many non‐genetic factors show non‐negligible impacts on personalized medicine. Emerging studies have demonstrated epigenetic could connect non‐genetic factors and individual treatment differences. We used systematic retrieval methods and reviewed studies that showed individual factors’ impact on DNA methylation of drug metabolism genes. In total, 68 studies were included, and half (n = 36) were cohort studies. Six aspects of individual factors were summarized from the perspective of personalized medicine: parental exposure, environmental pollutants exposure, obesity and diet, drugs, gender and others. The most research (n = 11) focused on ABCG1 methylation. The majority of studies showed non‐genetic factors could result in a significant DNA methylation alteration in drug metabolism genes, which subsequently affects the pharmacokinetic processes. However, the underlying mechanism remained unknown. Finally, some viewpoints were presented for future research.
Funder
Beijing Municipal Natural Science Foundation
Subject
Health, Toxicology and Mutagenesis,Genetics (clinical),Epidemiology
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Risk factors associated with high-dose methotrexate induced toxicities;Expert Opinion on Drug Metabolism & Toxicology;2024-03-19
2. Omics Sciences in Drug Discovery, Safety, and Pharmacokinetics;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024
3. Omics Sciences in Drug Discovery, Safety, and Pharmacokinetics;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024